LungLifeAI, a pioneer in LiquidBiopsy® technology, uses machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. Take a look at how Persistent’s ML algorithms have reduced analysis time by almost 70%, accelerating LungLife’s efforts to greatly reduce the impact of disease that claims around 400 lives per day.
Related Content
Contact us
(*) Asterisk denotes mandatory fields